Case Studies2020-11-19T22:10:23-08:00

Case Studies

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Gold Flora Corporation Files for Voluntary Receivership

COSTA MESA, Calif. , March 27, 2025 /CNW/ - Gold Flora Corporation ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB: GRAM), a cannabis company with subsidiaries operating across California, today announced that it filed for a voluntary receivership pursuant under ...

Federal Cannabis Trafficking Cases Reach Record Low

LOS ANGELES- The U.S. Sentencing Commission's 2024 Sourcebook of Federal Sentencing Statistics reveals a continued decline in federal cannabis trafficking cases. In 2024, fewer than 500 individuals were charged, marking a significant decrease from nearly ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

U.S. Cannabis Industry: Growth and Puzzles Across States

LOS ANGELES— The cannabis landscape in the U.S. is rapidly shifting, with each state crafting its narrative. From Maryland's remarkable entry to Michigan's booming market, Illinois's unique challenges, and Colorado's stellar tax earnings, the industry's ...

Filament Health Refiles Q2 Financial Results

LOS ANGELES-- Filament Health Corp. has refiled its second-quarter financial results for the period ending June 30, 2023, following an initial filing on May 12, 2023. The revision was necessitated by changes in the accounting ...

COMPASS Pathways Q2 2023 Financial Analysis

LOS ANGELES-- COMPASS Pathways, a biotech firm in the psychedelic medicine sector, has been under the spotlight since its inception. This year, the company's trajectory remains robust, as evidenced by its recent financial report and ...

Hydrofarm Holdings Group Reports Q2 2023 Financial Results

LOS ANGELES— Hydrofarm Holdings Group, Inc.  an independent manufacturer and distributor of hydroponics equipment and supplies for controlled environment agriculture, unveiled its financial results for the second quarter Key Takeaways from Q2 2023: Net Sales: ...

  • Curaleaf Holdings, Inc.

Curaleaf Holdings Inc. Reports Q2 2023

NEW YORK — Curaleaf Holdings Inc., a global provider of consumer cannabis products, has released its Q2 2023 financial results. The company has reported a 4% year-over-year revenue growth, totaling $339 million, amidst a dynamic ...

Subscribe To Our Newsletter

Go to Top